Accessibility Menu
 
International Stem Cell logo

International Stem Cell

(OTC) ISCO

Current Price$0.14
Market Cap$1.08M
Since IPO (2007)-100%
5 Year-81%
1 Year+13%
1 Month-19%

International Stem Cell Financials at a Glance

Market Cap

$1.08M

Revenue (TTM)

$9.10M

Net Income (TTM)

$418.00K

EPS (TTM)

$-0.06

P/E Ratio

-2.13

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$0.14

Volume

1

Open

$0.14

Previous Close

$0.14

Daily Range

$0.14 - $0.16

52-Week Range

$0.11 - $0.27

ISCO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About International Stem Cell

Industry

Biotechnology

Employees

33

CEO

Andrey Semechkin, PhD

Headquarters

San Diego, CA 92131, US

ISCO Financials

Key Financial Metrics (TTM)

Gross Margin

56%

Operating Margin

-3%

Net Income Margin

-5%

Return on Equity

-167%

Return on Capital

-1%

Return on Assets

-9%

Earnings Yield

-46.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.08M

Shares Outstanding

8.00M

Volume

1

Short Interest

0.00%

Avg. Volume

4.62K

Financials (TTM)

Gross Profit

$5.07M

Operating Income

$267.00K

EBITDA

$48.00K

Operating Cash Flow

$8.00K

Capital Expenditure

$43.00K

Free Cash Flow

$35.00K

Cash & ST Invst.

$993.00K

Total Debt

$3.73M

International Stem Cell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.15M

-11.9%

Gross Profit

$1.09M

-25.2%

Gross Margin

50.53%

N/A

Market Cap

$1.08M

N/A

Market Cap/Employee

$33.79K

N/A

Employees

32

N/A

Net Income

$348.00K

-3263.6%

EBITDA

$442.00K

-525.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.74M

-5.0%

Accounts Receivable

$723.00K

-31.7%

Inventory

$1.51M

+31.8%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$3.73M

+0.2%

Return on Assets

-8.67%

N/A

Return on Invested Capital

-1.11%

N/A

Free Cash Flow

$29.00K

+137.7%

Operating Cash Flow

$32.00K

+143.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIORBiora Therapeutics, Inc.
$0.22+0.00%
EVFMEvofem Biosciences, Inc.
$0.01+3.45%
UNBXUnity Biotechnology, Inc.
$0.06+0.00%
DTRKDATATRAK International, Inc.
$0.43+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About ISCO

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.